13 August 2019
Last week, NICE published draft recommendations on the use of cannabis-based medicinal products (CBMPs) following evaluation of their clinical and cost-effectiveness, and NHS England published a review aimed at assessing the barriers to prescribing cannabis-based medicinal products where it is safe ...
8 August 2019
Since 2014 the British Paediatric Surveillance Unit has held this annual event - young people living with rare disease and health professionals working in the field share their experiences. Our interns went along to find out more...
1 August 2019
You can now follow RCPCH on Instagram, the social networking channel! We're celebrating the lives of our members - and professionals working in child health - around the world. And to get things started, we've launched a photo competition for a chance to win £250 in gift vouchers.
31 May 2019
If as a society we are failing our most vulnerable, then surely we are a failing society. The RCPCH responds.
10 May 2019
Our first version is now ready for stress testing by a select group of parents and families from our charity partner, WellChild. If you're joining us at RCPCH Conference and exhibition on 13-15 May, come to our stand for a sneak preview!
29 March 2019
Experts from 13 national bodies, including seven Royal Colleges, have joined forces to launch new practical guidance to support doctors and other health professionals around valproate use in women and girls in their reproductive years.
1 February 2019
We have worked with NHS England on a programme to ensure children and young people with a learning disability, autism or both are able to access appropriate medication, and are not prescribed inappropriate psychotropic medication. Find out more and read our full pledge.
30 October 2018
RCPCH responds to new research which suggests these drugs may alter gut microbes associated with weight gain.
10 October 2018
To mark World Mental Health Day, the Prime Minister has made a series of announcements on mental health.
1 October 2018
The Department of Health & Social Care has issued urgent guidance relating to supply disruption of Mylan EpiPens for all health care professionals who prescribe, dispense or administer adrenaline auto-injectors.